🧬 Finally, muscle disease models that actually predict clinical success.

CYTOO disease modeling - DM1
CYTOO's MyoScreen™ transforms real patient cells into powerful screening tools that actually predict therapeutic success.

🎯 What sets us apart:

✓ Physiologically relevant disease hallmarks

✓ Multi-modal molecular readouts (RT-qPCR, RNA-seq, omics)

✓ Quantitative therapeutic rescue assessment

Take our DM1 models: they faithfully reproduce DMPK RNA foci, MBNL1 mislocalization, splicing defects, and calcium signaling alterations.

💊 Already powering multiple partner programs across gene therapies, small molecules, and oligonucleotides.

From inherited disorders to muscular dystrophies – we provide the robust models pharma needs.

Ready to test your therapeutic in disease-relevant conditions? Contact us ! 

Share:

More Posts

Join us on LinkedIn

Contact us